RxDoctor Payments Data

Blair Halperin, MD

Clinical Cardiac Electrophysiology · Bend, ORNPI 1447258710

Payments from drug & device makers

What this record shows

Abbott accounts for 90.9% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2023 at $3,410 and has fallen 58.7% since, to $1,408 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in OR, where the typical reported total is $7,720.

$6,980in general payments, 2019–2025

Across 107 payments — averaging $65.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$6K
  • Boston Scientific$227
  • Biosense Webster, Inc.$169
  • Cardiva Medical, Inc.$64
  • Pfizer$61
  • Johnson & Johnson$46
  • plus $70 from 2 others
$160,824in research payments, 2019–2025

Across 28 payments — averaging $5743.72 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boston Scientific$115K
  • Medtronic$46K

What the payments were for

  • Travel & lodging$3,52751%
  • Food & beverage$3,45349%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,980 in reported general payments places this provider in the 45th percentile of 37 clinical cardiac electrophysiology providers in Oregon.

See all clinical cardiac electrophysiology providers in Oregon

Medicare billing

Part B allowed, 2024
$155,416
Medicare patients
842
Services billed
1,476

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban371$532,081
XareltoRivaroxaban68$101,745
Flecainide Acetate169$9,177
Dofetilide69$9,010
SotalolSotalol Hcl161$3,620
Metoprolol Succinate142$2,591
Amiodarone Hcl142$2,477
Diltiazem 24hr Er (Cd)Diltiazem Hcl53$1,478
Diltiazem 24hr Er (Xr)Diltiazem Hcl27$1,263
Verapamil ErVerapamil Hcl15$555
Carvedilol41$498
Digoxin21$376
Warfarin Sodium32$296
Omeprazole21$214
Atenolol22$209

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$61$532,081371 claims
Johnson & JohnsonXarelto$46$101,74568 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 37 clinical cardiac electrophysiology providers in Oregon.

Other clinical cardiac electrophysiology in Bend

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →